Lung Cancer Drug, Osimertinib, Drastically Reduces Death Risk after Surgery – Lung Cancer Blog
Lung cancer is among most common types of cancers in U.S. as well as around the world. According to the Centers for Disease Control and Prevention, it is responsible for nearly a quarter of U.S. cancer deaths in the year 2020. According to the new trial findings, taking Tagrisso, also known as Osimertinib, a once-daily
